Fmr LLC Heron Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 342,305 shares of HRTX stock, worth $691,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares

342,305

Previous 319,943 6.99%

Holding current value

$691,456

Previous $886,000 35.21%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.32 - $3.86 $51,879 - $86,317	22,362 Added 6.99%	342,305 $1.2 Million
Q1 2024 May 13, 2024	BUY	$1.71 - $3.06 $513 - $918	300 Added 0.09%	319,943 $886,000
Q4 2023 Feb 13, 2024	BUY	$0.54 - $1.82 $21,137 - $71,242	39,144 Added 13.96%	319,643 $543,000
Q3 2023 Nov 13, 2023	BUY	$0.97 - $1.8 $4,143 - $7,689	4,272 Added 1.55%	280,499 $288,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.88 $154,799 - $401,641	139,459 Added 101.97%	276,227 $320,000
Q1 2023 May 11, 2023	BUY	$1.51 - $3.25 $978 - $2,106	648 Added 0.48%	136,768 $206,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $13,803 - $28,650	-6,135 Reduced 4.31%	136,120 $340,000
Q3 2022 Nov 10, 2022	BUY	$2.66 - $5.37 $5,551 - $11,207	2,087 Added 1.49%	142,255 $601,000
Q2 2022 Aug 12, 2022	BUY	$2.3 - $6.29 $12,348 - $33,771	5,369 Added 3.98%	140,168 $391,000
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $36,211 - $77,740	7,821 Added 6.16%	134,799 $771,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $4.29 Million - $6.47 Million	-513,632 Reduced 80.18%	126,978 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $97,521 - $144,405	9,627 Added 1.53%	640,610 $6.85 Million
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $8.37 Million - $11.7 Million	630,983 New	630,983 $9.79 Million

Others Institutions Holding HRTX

# of Institutions

198

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $240M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account